Overview

A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia

Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of the drug SM-13496 compared to a placebo and to haloperidol in patients with schizophrenia.
Phase:
Phase 2
Details
Lead Sponsor:
Sunovion
Treatments:
Haloperidol
Haloperidol decanoate
Lurasidone Hydrochloride